Your browser doesn't support javascript.
loading
BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA.
Coimbra, Felipe Jose F; Torres, Orlando Jorge M; Alikhanov, Ruslan; Agarwal, Anil; Pessaux, Patrick; Fernandes, Eduardo de Souza M; Quireze-Junior, Claudemiro; Araujo, Raphael Leonardo C; Godoy, André Luis; Waechter, Fabio Luis; Resende, Alexandre Prado de; Boff, Marcio Fernando; Coelho, Gustavo Rego; Rezende, Marcelo Bruno de; Linhares, Marcelo Moura; Belotto, Marcos; Moraes-Junior, Jose Maria A; Amaral, Paulo Cezar G; Pinto, Rinaldo Danesi; Genzini, Tercio; Lima, Agnaldo Soares; Ribeiro, Heber Salvador C; Ramos, Eduardo José; Anghinoni, Marciano; Pereira, Lucio Lucas; Enne, Marcelo; Sampaio, Adriano; Montagnini, André Luis; Diniz, Alessandro; Jesus, Victor Hugo Fonseca de; Sirohi, Bhawna; Shrikhande, Shailesh V; Peixoto, Renata D Alpino; Kalil, Antonio Nocchi; Jarufe, Nicolas; Smith, Martin; Herman, Paulo.
  • Coimbra FJF; Department of Gastrointestinal Surgery, AC Camargo Cancer Center, São Paulo, Brazil.
  • Torres OJM; Department of Hepatopancreatobiliary Surgery, Federal University of Maranhão, São Luis, Brazil.
  • Alikhanov R; Department of Hepatopancreatobiliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.
  • Agarwal A; Department of Gastrointestinal Surgery, Govind Ballabh Pant Hospital, New Delhi, India.
  • Pessaux P; Department of Hepatopancreatobiliary Surgery, Nouvel Hopital Civil, University Hospital of Strasbourg, Strasbourg, France.
  • Fernandes ESM; Department of Hepatopancreatobiliary and Transplant Surgery, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Quireze-Junior C; Department of Gastrointestinal Surgery, Federal University of Goiás, Goiânia, Brazil.
  • Araujo RLC; Department of Hepatobiliary Surgery, Federal University of São Paulo, São Paulo, Brazil.
  • Godoy AL; Department of Gastrointestinal Surgery, AC Camargo Cancer Center, São Paulo, Brazil.
  • Waechter FL; Department of Gastrointestinal Surgery, Santa Casa de Porto Alegre, Porto Alegre, Brazil.
  • Resende AP; Department of General Surgery, Mater Dei Hospital, Belo Horizonte, Brazil.
  • Boff MF; Department of Oncology Surgery, Mãe de Deus Hospital, Porto Alegre, Brazil.
  • Coelho GR; Department of Hepatopancreatobiliary Surgery, Hospital Walter Cantidio, Fortaleza, Brazil.
  • Rezende MB; Department of Hepatopancreatobiliary Surgery, Hospital Albert Einstein, São Paulo, Brazil.
  • Linhares MM; Department of Hepatobiliary Surgery, Federal University of São Paulo, São Paulo, Brazil.
  • Belotto M; Department of Gastrointestinal Surgery, Santa Casa de São Paulo, São Paulo, Brazil.
  • Moraes-Junior JMA; Department of Hepatopancreatobiliary Surgery, Federal University of Maranhão, São Luis, Brazil.
  • Amaral PCG; Department of Gastrointestinal Surgery, Hospital São Rafael, Salvador, Brazil.
  • Pinto RD; Department of Gastrointestinal Surgery, Hospital Santa Catarina, Blumenal, Brazil.
  • Genzini T; Department of Hepatopancreatobiliary Surgery, Hospital Beneficiência Portuguesa, São Paulo, Brazil.
  • Lima AS; Department of Hepatopancreatobiliary Surgery, Santa Casa de Belo Horizonte, Brazil.
  • Ribeiro HSC; Department of Gastrointestinal Surgery, AC Camargo Cancer Center, São Paulo, Brazil.
  • Ramos EJ; Department of Hepatopancreatobiliary Surgery, Hospital NS das Graças, Curitiba, Brazil.
  • Anghinoni M; Department of Oncology Surgery, Hospital São Vicente, Curitiba, Brazil.
  • Pereira LL; Department of Gastrointestinal Surgery, Hospital Sírio-Libanês, Brasilia, Brazil.
  • Enne M; Department of Hepatopancreatobiliary Surgery, Ipanema Hospital, Rio de Janeiro, Brazil.
  • Sampaio A; Department of Gastrointestinal Surgery, Santo Amaro University, São Paulo, Brazil.
  • Montagnini AL; Department of Hepatopancreatobiliary Surgery, São Paulo Medical School, São Paulo, Brazil.
  • Diniz A; Department of Gastrointestinal Surgery, AC Camargo Cancer Center, São Paulo, Brazil.
  • Jesus VHF; Department of Gastrointestinal Oncology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Sirohi B; Department of Hepatopancreatobiliary and Oncology Surgery, Tata Memorial Hospital, Mumbai, India.
  • Shrikhande SV; Department of Hepatopancreatobiliary and Oncology Surgery, Tata Memorial Hospital, Mumbai, India.
  • Peixoto RDA; Department of Gastrointestinal Oncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Kalil AN; Department of Gastrointestinal Oncology, Santa Casa de Porto Alegre, Porto Alegre, Brazil.
  • Jarufe N; Department of Hepatopancreatobiliary Surgery, Universidade Católica, Santiago, Chile.
  • Smith M; Department of Hepatopancreatobiliary Surgery, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
  • Herman P; Department of Hepatopancreatobiliary Surgery, São Paulo Medical School, São Paulo, Brazil.
Arq Bras Cir Dig ; 33(1): e1496, 2020 Jul 08.
Article en En, Pt | MEDLINE | ID: mdl-32667526
BACKGROUND: Incidental gallbladder cancer is defined as a cancer discovered by histological examination after cholecystectomy. It is a potentially curable disease. However, some questions related to their management remain controversial and a defined strategy is associated with better prognosis. AIM: To develop the first evidence-based consensus for management of patients with incidental gallbladder cancer in Brazil. METHODS: Sixteen questions were selected, and 36 Brazilian and International members were included to the answer them. The statements were based on current evident literature. The final report was sent to the members of the panel for agreement assessment. RESULTS: Intraoperative evaluation of the specimen, use of retrieval bags and routine histopathology is recommended. Complete preoperative evaluation is necessary and the reoperation should be performed once final staging is available. Evaluation of the cystic duct margin and routine 16b1 lymph node biopsy is recommended. Chemotherapy should be considered and chemoradiation therapy if microscopically positive surgical margins. Port site should be resected exceptionally. Staging laparoscopy before reoperation is recommended, but minimally invasive radical approach only in specialized minimally invasive hepatopancreatobiliary centers. The extent of liver resection is acceptable if R0 resection is achieved. Standard lymph node dissection is required for T2 tumors and above, but common bile duct resection is not recommended routinely. CONCLUSIONS: It was possible to prepare safe recommendations as guidance for incidental gallbladder carcinoma, addressing the most frequent topics of everyday work of digestive and general surgeons.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vesícula Biliar Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País como asunto: America do sul / Brasil Idioma: En / Pt Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vesícula Biliar Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans País como asunto: America do sul / Brasil Idioma: En / Pt Año: 2020 Tipo del documento: Article